Skip to content
ETopical – Lifestyle
Home
Sample Page
Author:
Telix Pharmaceuticals Limited
Telix Strengthens Board with Additional Director Appointments
April 8, 2026
Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement
April 7, 2026
Telix Appoints David Gill as Non-Executive Director
April 1, 2026
Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate
March 15, 2026
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
March 9, 2026
←
Previous Page
1
2